Apotex Asks DC Circ. To Stay Teva's Hyzaar Exclusivity
Apotex Inc. has asked a federal appeals court to bar Teva Pharmaceuticals USA Inc. from gaining a 180-day exclusivity period on generic versions of Merck & Co. Inc. hypertension drugs Hyzaar...To view the full article, register now.
Already a subscriber? Click here to view full article